The pre-treatment of A. muciniphila to colitis mice not only stabilized the colon mucosal barrier, regulated inflammatory cytokines (e.g., TNF-α, IL-6) and chemokines MIP-1, but also alleviated dysbiosis of the gut microbiome. This evidence concerns the gene TNF and colitis.